IP Verse

Pharmaceutical Formulations

Patent No. EP4070787 (titled "Pharmaceutical Formulations") was filed by Gilead Sciences on Jun 29, 2016. The application was issued on Mar 1, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ZENTIVANov 29, 2023REDDIE & GROSE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4070787

GILEAD SCIENCES
Application Number
EP22176524A
Filing Date
Jun 29, 2016
Status
Granted And Under Opposition
Jan 27, 2023
Publication Date
Mar 1, 2023
External Links
Slate, Register , Google Patents